Intel Corporation (NASDAQ: INTC) saw its shares tick up 0.3% to $89.74 in premarket trading on Monday, August 31, 2026, following a 2.85% decline on Friday. The stock remains 5.5% below the $95 per-share offering price from its recent capital raise, a gap that investors are closely monitoring.
The company raised approximately $19.7 billion in net proceeds through the issuance of 210.5 million new shares, representing an estimated 4.1% dilution based on its projected second-quarter share base. The base tranche value has since fallen to around $18.9 billion, roughly $1.1 billion less than the initial issue value, reflecting the stock's underperformance relative to the offering price.
Strong Q2 Results and Growth Drivers
Intel's second-quarter results, released earlier this month, showed robust growth. Revenue increased 25% year-over-year to $16.1 billion, while GAAP gross margin expanded by 12.9 percentage points to 40.4%. Non-GAAP gross margin rose to 41.8%, up 12.1 points from the prior year.
The Data Center and AI segment was a standout performer, with revenue surging 59% to $6.3 billion, now accounting for 39% of total net sales. Foundry revenue also grew 31% to $5.8 billion, underscoring the company's progress in its manufacturing expansion.
Capital Raise and Dilution Concerns
The capital raise, which included an option for underwriters to purchase additional shares, could bring total new shares to 242.1 million, potentially increasing dilution to as much as 4.8%. Intel stated that the proceeds would be used for capital expenditures and working capital, supporting its investments in equipment, clean rooms, and substrate supply.
However, the discount to the offering price highlights investor concerns about whether the new capital will generate sufficient returns to offset the dilution. The company's operating cash flow for the quarter was $7.0 billion, which is strong, but the capital hurdle remains high.
Valuation and Analyst Outlook
Intel's valuation continues to reflect expectations of a sharp recovery. The stock trades at approximately 59.8 times the consensus 2026 EPS estimate of $1.50, and 43.4 times the 2027 estimate of $2.07. Analyst price targets range from a low of $75 to a high of $200, with a median of $116 and an average of $121.24, implying potential upside of 29.3% to 35.1% from current levels.
Among 54 analysts covering the stock, 15 rate it a Buy, five Overweight, 32 Hold, and two Sell. The consensus recommendation is Overweight.
Forward Guidance and Risks
For the third quarter, Intel guides revenue between $15.8 billion and $16.8 billion, with a midpoint of $16.3 billion, indicating near-flat sequential growth. Strong annual comparisons are expected, but investors will watch for execution on margins and cash conversion.
Key risks include potential manufacturing delays, underutilized foundry capacity, and the possibility of additional share offerings that could further dilute existing shareholders. The company's ability to bridge the gap to the $95 offering price will depend on sustaining operational momentum and delivering on its growth initiatives.
As of Monday premarket, Intel's stock was among the most active on NASDAQ, with premarket volume indicating continued investor interest. The stock's performance relative to the offering price will remain a key indicator of market confidence in Intel's turnaround strategy.
